Advertisement
Senator scrutinizes pharma links on government pain panel

Senator scrutinizes pharma links on government pain panel

By Associated Press  |  February 08, 2016

Sen. Ron Wyden says he has "a number of concerns" about how panelists were selected and screened for an advisory panel on pain issues that includes government experts, outside academics and patient advocates.

Blog: Opioid abuse in 1960s pales compared to today's overdose epidemic

By Jay Greene, Crain's Detroit Business  |  February 08, 2016

Opioid drug abuse is reaching epidemic proportions, with thousands of deaths each year along with many more lives and families ruined—just ask any healthcare expert, public health researcher, politician or law enforcement official.

Ghostface Killah is pharma bad boy's newest target

Ghostface Killah is pharma bad boy's newest target

By Modern Healthcare  |  February 06, 2016

In the mid-1990s, hip-hop artists Tupac Shakur and The Notorious B.I.G. engaged in a legendary feud that involved both sides of the country, the East and West coasts. Both men wound up dead.

Doctor gets 30 years to life for prescription drug deaths

By Associated Press  |  February 05, 2016

A doctor convicted of murder for prescribing exorbitant amounts of painkillers that left three patients dead was sentenced Friday to 30 years to life in prison. The doctor was accused of prescribing "crazy, outrageous amounts of medication" to patients who didn't even need the drugs.

Could Massachusetts have the tool to fix high drug costs?

Could Massachusetts have the tool to fix high drug costs?

By Lisa Schencker  |  February 03, 2016

There might be another tool in the battle against high drug costs: state consumer protection laws. A potential lawsuit in Massachusetts against drugmaker Gilead over its costly hepatitis C drugs could, if successful, forge a new path for states working to combat the high costs of certain drugs.

Pfizer earnings fall but top Wall Street 4Q forecasts

By Associated Press  |  February 02, 2016

Pfizer's fourth-quarter profit fell by half due to higher costs for production, administration and restructuring, but new revenue from an acquisition helped the world's second-biggest drugmaker beat Wall Street expectations.

Congress says drugmakers planned price hikes to boost profits

By Associated Press  |  February 02, 2016

A congressional review of more than 300,000 pages from Turing Pharmaceuticals and Valeant Pharmaceuticals reveals how executives planned to maximize profits while fending off negative publicity over the price hikes.

Sanofi in search of Zika vaccine as first sexually transmitted case appears

By Associated Press  |  February 02, 2016

Health officials say a patient in Dallas County, Texas, has acquired the Zika virus through sex. Drugmaker Sanofi Pasteur is researching and developing a vaccine after the World Health Organization declared a global emergency over its explosive spread across the Americas.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.